Traws Pharma, Inc.TRAWNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-859.78%
↑ 93% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-11635.87%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -859.78% | +98.8% |
| 2024 | -73677.43% | -721.0% |
| 2023 | -8974.34% | -3.4% |
| 2022 | -8678.32% | -19.0% |
| 2021 | -7292.92% | +32.6% |
| 2020 | -10813.85% | -988.6% |
| 2019 | -993.36% | +40.4% |
| 2018 | -1667.67% | +45.3% |
| 2017 | -3048.41% | -764.5% |
| 2016 | -352.63% | - |